Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate in Diabetic Nephropathy
NCT01869881Phase 4Completed
- Sponsor
- Yuhan
- Start
- Feb 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic nephropathy (DN) comparing Sarpogrelate with Placebo (2 arms). Primary endpoint: Urine Albumin/Creatinine ratio at 24 weeks. Started Feb 2013; status: completed.
02
Drugs
sarpogrelate
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01869881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01869881.